• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢中的 D-手性肌醇悖论。

The D-chiro-inositol paradox in the ovary.

机构信息

Associazione Ginecologi Unfer Costabile (AGUNCO) Obstetrics and Gynecology Center, Rome, Italy.

出版信息

Fertil Steril. 2011 Jun 30;95(8):2515-6. doi: 10.1016/j.fertnstert.2011.05.027. Epub 2011 Jun 8.

DOI:10.1016/j.fertnstert.2011.05.027
PMID:21641593
Abstract

The D-chiro-inositol-to-myo-inositol ratio is regulated by an insulin-dependent epimerase. Enzyme activity varies among tissues, likely owing to the specific needs of the two different molecules. We hypothesize that in the ovaries of polycystic ovary syndrome patients, epimerase activity is enhanced, leading to a local myo-inositol deficiency which in turn is responsible for the poor oocyte quality.

摘要

D-手性肌醇与肌醇的比例受胰岛素依赖的差向异构酶调控。由于两种不同分子的特殊需求,酶活性在不同组织中存在差异。我们假设,在多囊卵巢综合征患者的卵巢中,差向异构酶活性增强,导致局部肌醇缺乏,进而导致卵子质量差。

相似文献

1
The D-chiro-inositol paradox in the ovary.卵巢中的 D-手性肌醇悖论。
Fertil Steril. 2011 Jun 30;95(8):2515-6. doi: 10.1016/j.fertnstert.2011.05.027. Epub 2011 Jun 8.
2
Reflections on inositol(s) for PCOS therapy: steps toward success.多囊卵巢综合征治疗中肌醇的思考:迈向成功的步骤
Gynecol Endocrinol. 2015 Jul;31(7):501-5. doi: 10.3109/09513590.2015.1054802. Epub 2015 Jul 15.
3
Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.D-手性肌醇对多囊卵巢综合征的排卵及代谢影响
N Engl J Med. 1999 Apr 29;340(17):1314-20. doi: 10.1056/NEJM199904293401703.
4
Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction.再见了手性肌醇——米糠醇:多囊卵巢综合征和排卵诱导治疗的真正进展。
Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1212-4.
5
Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.肌醇磷酸聚糖胰岛素作用介质在多囊卵巢综合征中的作用
J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1295-8.
6
Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.多囊卵巢综合征中的肌醇:基于病理生理学的方法恢复生育能力。
Trends Endocrinol Metab. 2018 Nov;29(11):768-780. doi: 10.1016/j.tem.2018.09.001. Epub 2018 Sep 27.
7
Potential role and therapeutic interests of myo-inositol in metabolic diseases.肌醇在代谢性疾病中的潜在作用和治疗意义。
Biochimie. 2013 Oct;95(10):1811-27. doi: 10.1016/j.biochi.2013.05.011. Epub 2013 Jun 10.
8
Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls.多囊卵巢综合征(PCOS)卵泡膜细胞中肌醇与手性肌醇(M/C)的比例降低,且M/C表异构酶活性增加,这表明与对照组相比,其胰岛素敏感性增强。
Endocr J. 2014;61(2):111-7. doi: 10.1507/endocrj.ej13-0423. Epub 2013 Nov 2.
9
Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.肌醇而非 D-手性肌醇能够改善卵胞浆内单精子注射周期中的卵子质量。一项前瞻性、对照、随机试验。
Eur Rev Med Pharmacol Sci. 2011 Apr;15(4):452-7.
10
Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS.多囊卵巢综合征中病理性甾体生成的原因可能是卵巢肌醇比值改变。
Int J Mol Sci. 2020 Sep 28;21(19):7157. doi: 10.3390/ijms21197157.

引用本文的文献

1
PCOS and Inositols - Advances and Lessons We are Learning. A Narrative Review.多囊卵巢综合征与肌醇——我们正在汲取的进展与经验。一篇叙述性综述。
Drug Des Devel Ther. 2025 May 21;19:4183-4199. doi: 10.2147/DDDT.S524718. eCollection 2025.
2
Reviewing Glycosyl-Inositols: Natural Occurrence, Biological Roles, and Synthetic Techniques.糖基肌醇综述:天然存在、生物学作用及合成技术
Chembiochem. 2025 Mar 15;26(6):e202400823. doi: 10.1002/cbic.202400823. Epub 2025 Mar 2.
3
The latest reports and treatment methods on polycystic ovary syndrome.
多囊卵巢综合征的最新报告和治疗方法。
Ann Med. 2024 Dec;56(1):2357737. doi: 10.1080/07853890.2024.2357737. Epub 2024 Jul 4.
4
Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports.采用专利的3.6:1肌醇与D-手性肌醇比例、抗氧化剂、维生素和矿物质的食品补充剂治疗有辅助生殖技术(ART)失败史的女性:一系列病例报告。
Clin Med Insights Case Rep. 2024 Mar 29;17:11795476241242265. doi: 10.1177/11795476241242265. eCollection 2024.
5
<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).《临床实践中的 D-手性肌醇:基础与临床研究手性肌醇专家组(EGOI)的观点》。
Gynecol Obstet Invest. 2024;89(4):284-294. doi: 10.1159/000536081. Epub 2024 Feb 19.
6
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.40:1 配比的肌醇和 D-手性肌醇对按照 Rotterdam 标准分类为表型 A 及按照 EGOI 标准分类为 EMS 类型 1 的多囊卵巢综合征女性的激素和代谢特征的影响。
Gynecol Obstet Invest. 2024;89(2):131-139. doi: 10.1159/000536163. Epub 2024 Jan 31.
7
Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition.手性立体选择伏安生物传感器用于肌醇和 D-手性肌醇的识别。
Sensors (Basel). 2023 Nov 16;23(22):9211. doi: 10.3390/s23229211.
8
A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System.一项针对多囊卵巢综合征患者 IVF 项目的马尔可夫模型模拟表明,肌醇与 rFSH 联合使用在意大利卫生系统中具有成本效益。
Sci Rep. 2023 Oct 18;13(1):17789. doi: 10.1038/s41598-023-44055-0.
9
Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review.肌醇和 D-手性肌醇作为卵巢甾体激素生成的调节剂:叙述性综述。
Nutrients. 2023 Apr 13;15(8):1875. doi: 10.3390/nu15081875.
10
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.多囊卵巢综合征高雄激素表型中肌醇的作用:重新解读拉纳的研究结果。
Int J Mol Sci. 2023 Mar 27;24(7):6296. doi: 10.3390/ijms24076296.